615 related articles for article (PubMed ID: 24841868)
21. Chemotherapy is associated with increased survival from colorectal signet ring cell carcinoma with distant metastasis: A Surveillance, Epidemiology, and End Results database analysis.
Shi T; Huang M; Han D; Tang X; Chen Y; Li Z; Liu C; Xiang D; Wang T; Chen Y; Wang R; Lei Z; Chu X
Cancer Med; 2019 Apr; 8(4):1930-1940. PubMed ID: 30864303
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological characteristics and outcomes in stage I-III mucinous gastric adenocarcinoma: a retrospective study at a single medical center.
Hsu JT; Wang CW; Le PH; Wu RC; Chen TH; Chiang KC; Lin CJ; Yeh TS
World J Surg Oncol; 2016 Apr; 14():123. PubMed ID: 27112436
[TBL] [Abstract][Full Text] [Related]
23. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype.
Hugen N; van de Velde CJH; de Wilt JHW; Nagtegaal ID
Ann Oncol; 2014 Mar; 25(3):651-657. PubMed ID: 24504447
[TBL] [Abstract][Full Text] [Related]
24. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
Han SW; Lee HJ; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Int J Cancer; 2013 May; 132(9):2209-16. PubMed ID: 23034738
[TBL] [Abstract][Full Text] [Related]
25. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
26. Propensity-Score Matched Analysis of Survival Outcomes of Adjuvant Therapy in Stage II-III Signet-Ring Cell Carcinoma of the Colon.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Strassmann V; Wexner SD
Clin Colorectal Cancer; 2024 Mar; 23(1):35-45. PubMed ID: 37980215
[TBL] [Abstract][Full Text] [Related]
27. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study.
Bertelsen CA; Neuenschwander AU; Jansen JE; Wilhelmsen M; Kirkegaard-Klitbo A; Tenma JR; Bols B; Ingeholm P; Rasmussen LA; Jepsen LV; Iversen ER; Kristensen B; Gögenur I;
Lancet Oncol; 2015 Feb; 16(2):161-8. PubMed ID: 25555421
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach.
Bozkaya Y; Erdem GU; Ozdemir NY; Demirci NS; Hocazade C; Yazıcı O; Zengin N
Curr Med Res Opin; 2017 Jan; 33(1):109-116. PubMed ID: 27646639
[TBL] [Abstract][Full Text] [Related]
29. Inverse effect of mucinous component on survival in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Yamamoto G; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(7):851-7. PubMed ID: 25111953
[TBL] [Abstract][Full Text] [Related]
30. Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohort.
Nitsche U; Friess H; Agha A; Angele M; Eckel R; Heitland W; Jauch KW; Krenz D; Nüssler NC; Rau HG; Ruppert R; Schubert-Fritschle G; Wilhelm D; Werner J; Engel J
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2357-66. PubMed ID: 27573386
[TBL] [Abstract][Full Text] [Related]
31. Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology.
van Oudheusden TR; Braam HJ; Nienhuijs SW; Wiezer MJ; van Ramshorst B; Luyer P; de Hingh IH
J Surg Oncol; 2015 Feb; 111(2):237-42. PubMed ID: 25195780
[TBL] [Abstract][Full Text] [Related]
32. Prognosis and value of preoperative radiotherapy in locally advanced rectal signet-ring cell carcinoma.
Ling CR; Wang R; Wang MJ; Ping J; Zhuang W
Sci Rep; 2017 Mar; 7():45334. PubMed ID: 28345614
[TBL] [Abstract][Full Text] [Related]
33. The prognostic relevance of histologic subtype in appendiceal adenocarcinoma.
Legué LM; van Erning FN; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
Eur J Surg Oncol; 2020 Mar; 46(3):433-438. PubMed ID: 31668980
[TBL] [Abstract][Full Text] [Related]
34. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution.
Misirlioglu HC; Coskun-Breuneval M; Kucukpilakci B; Ugur VI; Elgin Y; Demirkasimoglu T; Kara SP; Ozgen A; Sanri E; Guney Y
Asian Pac J Cancer Prev; 2014; 15(20):8871-6. PubMed ID: 25374221
[TBL] [Abstract][Full Text] [Related]
36. [Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].
Benedix F; Kuester D; Meyer F; Lippert H
Zentralbl Chir; 2013 Aug; 138(4):427-33. PubMed ID: 22274919
[TBL] [Abstract][Full Text] [Related]
37. Prognosis of three histological subtypes of colorectal adenocarcinoma: A retrospective analysis of 8005 Chinese patients.
Li C; Zheng H; Jia H; Huang D; Gu W; Cai S; Zhu J
Cancer Med; 2019 Jul; 8(7):3411-3419. PubMed ID: 31074597
[TBL] [Abstract][Full Text] [Related]
38. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
[TBL] [Abstract][Full Text] [Related]
39. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation.
Li F; Liu L; Feng Q; Wang X; Liu F; Yang L; Miao L; Wang W; Ji G; Yu C
World J Surg Oncol; 2024 Apr; 22(1):107. PubMed ID: 38644507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
